20/20 Biolabs, Inc.

AIDX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001213900-26-023758
Filing date: Mar 4, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Cohen Jonathan M (CEO)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock Option

Action

Grant

Date

2026-03-03

Code

A

Net shares

+352,936.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

352,936.0

Filing's footnotes

1. On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.